Processing

Please wait...

Settings

Settings

Goto Application

1. WO2012056251 - INFLAMMATORY DISEASE

Publication Number WO/2012/056251
Publication Date 03.05.2012
International Application No. PCT/GB2011/052115
International Filing Date 31.10.2011
IPC
A61K 9/06 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
06Ointments; Bases therefor
A61K 9/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
A61K 31/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
CPC
A61K 31/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
A61K 31/192
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
19Carboxylic acids, e.g. valproic acid
192having aromatic groups, e.g. sulindac, 2-arylpropionic acids, ethacrynic acid
A61K 31/55
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
55having seven-membered rings, e.g. azelastine, pentylenetetrazole
A61K 47/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
08containing oxygen, ; e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
A61K 47/14
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
08containing oxygen, ; e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
A61K 47/44
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Applicants
  • BIOCOPEA LIMITED [GB]/[GB] (AllExceptUS)
  • BANNISTER, Robin Mark [GB]/[GB] (UsOnly)
  • BREW, John [GB]/[GB] (UsOnly)
  • STOLOFF, Gregory Alan [GB]/[GB] (UsOnly)
  • CAPAROSS-WANDERLEY, Wilson [GB]/[GB] (UsOnly)
  • PLEGUEZUELOS MATEO, Olga [ES]/[GB] (UsOnly)
Inventors
  • BANNISTER, Robin Mark
  • BREW, John
  • STOLOFF, Gregory Alan
  • CAPAROSS-WANDERLEY, Wilson
  • PLEGUEZUELOS MATEO, Olga
Agents
  • STEVENS, Fiona
Priority Data
1018289.729.10.2010GB
1113728.810.08.2011GB
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) INFLAMMATORY DISEASE
(FR) MALADIE INFLAMMATOIRE
Abstract
(EN)
The invention relates to the treatment of inflammatory diseases, and especially Th-1 mediated inflammatory diseases. In particular, the invention relates to the treatment of Th-1 mediated inflammatory diseases using a range of compositions, and to the use of these compositions in methods of treatment. The invention extends to adjuvants, for use in treating a wide variety of medical conditions. The invention also provides pharmaceutical compositions and medicaments comprising the adjuvant, and to uses of the adjuvant in methods of treatment and for eliciting an immune response.
(FR)
L'invention porte sur le traitement de maladies inflammatoires et, en particulier, de maladies inflammatoires médiées par Th-1. En particulier, l'invention porte sur le traitement de maladies inflammatoires médiées par Th-1 à l'aide d'une gamme de compositions, et sur l'utilisation de ces compositions dans des procédés de traitement. L'invention s'étend à des adjuvants destinés à être utilisés dans le traitement d'une grande diversité d'états médicaux. L'invention porte également sur des compositions pharmaceutiques et des médicaments comprenant l'adjuvant, et sur des utilisations de l'adjuvant dans des procédés de traitement et pour déclencher une réponse immunitaire.
Latest bibliographic data on file with the International Bureau